Scholarlink

<p>Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 12.5 million individuals globally and is one of the most common causes of end-stage renal disease. It is typically associated with a gradual increase in the volume of numerous cysts in both kidneys. Recent studies have highlighted the critical role of signal transducer and activator of transcription 3 (STAT3) in ADPKD pathogenesis, as it is highly expressed and persistently activated in ADPKD kidneys. Through screening of our in-house compound library, we identified compound <b>WR-S-647</b> (<b>4e</b>) as a potent and specific inhibitor of STAT3 with a binding affinity of 34&#xa0;nM to STAT3. <b>WR-S-647</b> suppressed the phosphorylation activation and nuclear localization of STAT3. In vitro, <b>WR-S-647</b> remarkably suppressed cyst formation and expansion in a Madin-Darby canine kidney (MDCK) cyst model. Meanwhile, it effectively diminished cyst growth in an ex vivo embryonal renal cyst model and an in vivo<i> Pkd1</i> knockout ADPKD mouse model. Our study identifies <b>WR-S-647</b> as a potent STAT3-mediated inhibitor and provides preclinical proof-of-concept for its efficacy in reducing cyst growth in ADPKD models.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD

  • 期刊论文

  • 发表日期：

    2026年1月1日

查看全文
  • Zhaoyong Kang,
  • Wenchao Zhao,
  • Wangrui Jin,
  • Yongzhan Sun,
  • Yangrui Peng,
  • Jiemin Wong,
  • Dong Guo,
  • Yihua Chen

摘要

Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 12.5 million individuals globally and is one of the most common causes of end-stage renal disease. It is typically associated with a gradual increase in the volume of numerous cysts in both kidneys. Recent studies have highlighted the critical role of signal transducer and activator of transcription 3 (STAT3) in ADPKD pathogenesis, as it is highly expressed and persistently activated in ADPKD kidneys. Through screening of our in-house compound library, we identified compound WR-S-647 (4e) as a potent and specific inhibitor of STAT3 with a binding affinity of 34 nM to STAT3. WR-S-647 suppressed the phosphorylation activation and nuclear localization of STAT3. In vitro, WR-S-647 remarkably suppressed cyst formation and expansion in a Madin-Darby canine kidney (MDCK) cyst model. Meanwhile, it effectively diminished cyst growth in an ex vivo embryonal renal cyst model and an in vivo Pkd1 knockout ADPKD mouse model. Our study identifies WR-S-647 as a potent STAT3-mediated inhibitor and provides preclinical proof-of-concept for its efficacy in reducing cyst growth in ADPKD models.